{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:04:32Z","timestamp":1768349072583,"version":"3.49.0"},"reference-count":148,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00450","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T09:56:18Z","timestamp":1459418178000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections"],"prefix":"10.3389","volume":"7","author":[{"given":"Malak M.","family":"Alame","sequence":"first","affiliation":[]},{"given":"Elie","family":"Massaad","sequence":"additional","affiliation":[]},{"given":"Hassan","family":"Zaraket","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1017\/S0950268810003122","article-title":"An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges.","volume":"139","author":"Abdelwhab","year":"2011","journal-title":"Epidemiol. Infect."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/infdis\/jir610","article-title":"Parenteral peramivir treatment for oseltamivir-resistant 2009 pandemic influenza A H1N1 viruses.","volume":"204","author":"Abed","year":"2011","journal-title":"J. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1128\/AAC.00753-12","article-title":"Therapeutic activity of intramuscular peramivir in mice infected with a recombinant influenza A\/WSN\/33 (H1N1) virus containing the H275Y neuraminidase mutation.","volume":"56","author":"Abed","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1128\/AAC.01681-09","article-title":"Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A\/WSN\/33 (H1N1) virus containing the H274Y neuraminidase mutation.","volume":"54","author":"Abed","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B5","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1155\/2009\/578179","article-title":"Is H9N2 avian influenza virus a pandemic potential?","volume":"20","author":"Alexander","year":"2009","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1177\/0091270011414574","article-title":"Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.","volume":"52","author":"Atiee","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"e0131412","key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131412","article-title":"Detection of peramivir and laninamivir, new anti-influenza drugs, in sewage e\ufb04uent and river waters in Japan.","volume":"10","author":"Azuma","year":"2015","journal-title":"PLoS ONE"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1021\/jm0002679","article-title":"BCX-1812 (RWJ-270201):? discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.","volume":"43","author":"Babu","year":"2000","journal-title":"J. Med. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.","volume":"89","author":"Baek","year":"2015","journal-title":"J. Virol."},{"issue":"e55271","key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055271","article-title":"Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay.","volume":"8","author":"Balgi","year":"2013","journal-title":"PLoS ONE"},{"issue":"e68450","key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068450","article-title":"High-content analysis of sequential events during the early phase of influenza A virus infection.","volume":"8","author":"Banerjee","year":"2013","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.antiviral.2005.10.002","article-title":"Anti-influenza virus activity of peramivir in mice with single intramuscular injection.","volume":"69","author":"Bantia","year":"2006","journal-title":"Antiviral Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.antiviral.2011.02.001","article-title":"A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A\/California\/04\/2009 (H1N1) influenza virus infection in mice.","volume":"90","author":"Bantia","year":"2011","journal-title":"Antiviral Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.antiviral.2010.09.020","article-title":"Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.","volume":"88","author":"Bantia","year":"2010","journal-title":"Antiviral Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.45.4.1162-1167.2001","article-title":"Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.","volume":"45","author":"Bantia","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/135965350501000805","article-title":"Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.","volume":"10","author":"Barroso","year":"2005","journal-title":"Antivir. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1128\/JVI.01225-13","article-title":"New small molecule entry inhibitors targeting hemagglutinin-mediated influenza A virus fusion.","volume":"88","author":"Basu","year":"2014","journal-title":"J. Virol."},{"key":"B19","author":"BioCryst Pharmaceuticals","year":"2015","journal-title":"A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety of Intramuscular Peramivir 600 mg in Subjects With Uncomplicated Acute Influenza - Full Text View - ClinicalTrials.gov."},{"key":"B20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.antiviral.2008.05.012","article-title":"Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.","volume":"80","author":"Boltz","year":"2008","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1460-2075.1992.tb05026.x","article-title":"The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.","volume":"11","author":"Burmeister","year":"1992","journal-title":"EMBO J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.antiviral.2013.08.023","article-title":"Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.","volume":"100","author":"Burnham","year":"2013","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1177\/0091270012440280","article-title":"Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.","volume":"53","author":"Chairat","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.antiviral.2013.06.014","article-title":"Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses.","volume":"99","author":"Chen","year":"2013","journal-title":"Antiviral Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejmech.2015.02.006","article-title":"Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.","volume":"93","author":"Chen","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/AOG.0b013e31821b1b3e","article-title":"Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza: a case report.","volume":"118","author":"Clay","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/pro.5560031007","article-title":"Influenza virus neuraminidase: structure, antibodies, and inhibitors.","volume":"3","author":"Colman","year":"1994","journal-title":"Protein Sci."},{"key":"B28","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1128\/JVI.67.6.2972-2980.1993","article-title":"Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.","volume":"67","author":"Colman","year":"1993","journal-title":"J. Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/303041a0","article-title":"Structure of the catalytic and antigenic sites in influenza virus neuraminidase.","volume":"303","author":"Colman","year":"1983","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.med.51.1.407","article-title":"Global epidemiology of influenza: past and present.","volume":"51","author":"Cox","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3201\/eid1603.091321","article-title":"Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs.","volume":"16","author":"Dapat","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1093\/cid\/ciu632","article-title":"Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.","volume":"59","author":"de Jong","year":"2014","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"issue":"e1001329","key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001329","article-title":"Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway.","volume":"7","author":"de Vries","year":"2011","journal-title":"PLoS Pathog."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1128\/AAC.45.7.2115-2118.2001","article-title":"Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing.","volume":"45","author":"Drusano","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"issue":"e1002830","key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002830","article-title":"Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonuclease.","volume":"8","author":"DuBois","year":"2012","journal-title":"PLoS Pathog."},{"key":"B36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1099\/vir.0.059477-0","article-title":"Entry of influenza A virus: host factors and antiviral targets.","volume":"95","author":"Edinger","year":"2014","journal-title":"J. Gen. Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7255","DOI":"10.1128\/AAC.01885-15.","article-title":"Assessment of antiviral properties of Peramivir against H7N9 avian influenza virus in an experimental mouse model.","volume":"59","author":"Farooqui","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B38","author":"Food and Drug Administration","year":"2015a","journal-title":"Press Announcements: FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings."},{"key":"B39","author":"Food and Drug Administration","year":"2015b","journal-title":"RAPIVABTM (Peramivir Injection), for Intravenous use Initial U.S. Approval 2014: Highlights of Prescribing Information."},{"key":"B40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor.","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus.","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1128\/AAC.45.10.2723-2732.2001","article-title":"Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and Other avian influenza viruses.","volume":"45","author":"Govorkova","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/v2081510","article-title":"Combination chemotherapy for influenza.","volume":"2","author":"Govorkova","year":"2010","journal-title":"Viruses"},{"key":"B44","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1128\/AAC.45.12.3403-3408.2001","article-title":"Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.","volume":"45","author":"Gubareva","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1473-3099(14)70717-0","article-title":"Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b\/3 trial.","volume":"14","author":"Haffizulla","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/v4071144","article-title":"Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion.","volume":"4","author":"Hamilton","year":"2012","journal-title":"Viruses"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.2169\/internalmedicine.53.2330","article-title":"Severe immune thrombocytopenia possibly elicited by the anti-influenza viral agent peramivir.","volume":"53","author":"Harada-Shirado","year":"2014","journal-title":"Intern. Med."},{"issue":"65","key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-9-65","article-title":"Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.","volume":"9","author":"Hartshorn","year":"2008","journal-title":"Respir. Res."},{"key":"B49","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.40.5.1304","article-title":"Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.","volume":"40","author":"Hastings","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"B50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7883\/yoken.JJID.2007.202","article-title":"High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.","volume":"60","author":"Hata","year":"2007","journal-title":"Jpn. J. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","article-title":"Molecular basis of resistance of influenza A viruses to amantadine.","volume":"18","author":"Hay","year":"1986","journal-title":"J. Antimicrob. Chemother."},{"key":"B52","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/mus.24594","article-title":"Exacerbation of myasthenia gravis by intravenous peramivir.","volume":"51","author":"Hayashi","year":"2015","journal-title":"Muscle Nerve"},{"key":"B53","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"48","author":"Hayden","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/cid\/cir001","article-title":"Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an emergency IND program in the united states.","volume":"52","author":"Hernandez","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1128\/JCM.00682-12","article-title":"Recovery of influenza B virus with the H273Y point mutation in the neuraminidase active site from a human patient.","volume":"50","author":"Higgins","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"e834181","key":"B57","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/834181","article-title":"Clinical effectiveness of peramivir in comparison with other neuraminidase inhibitors in pediatric influenza patients.","volume":"2012","author":"Hikita","year":"2012","journal-title":"Int. J. Pediatr."},{"key":"B58","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jiac.2013.07.002","article-title":"In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.","volume":"20","author":"Ikematsu","year":"2014","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"B59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jiac.2014.08.030","article-title":"In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season.","volume":"21","author":"Ikematsu","year":"2015a","journal-title":"J. Infect. Chemother. Off. J. Jpn. Soc. Chemother."},{"key":"B60","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jiac.2015.05.004","article-title":"In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013\u20132014 season.","volume":"21","author":"Ikematsu","year":"2015b","journal-title":"J. Infect. Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.coviro.2011.09.002","article-title":"Antivirals and resistance: influenza virus.","volume":"1","author":"Ison","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3851\/IMP2680","article-title":"Intravenous peramivir for treatment of influenza in hospitalized patients.","volume":"19","author":"Ison","year":"2014","journal-title":"Antivir. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3851\/IMP2442","article-title":"A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.","volume":"18","author":"Ison","year":"2013","journal-title":"Antivir. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1128\/AAC.00793-15","article-title":"Emergence of H7N9 influenza A virus resistant to neuraminidase inhibitors in nonhuman primates.","volume":"59","author":"Itoh","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1208\/ps040422","article-title":"Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers.","volume":"4","author":"Iyer","year":"2002","journal-title":"AAPS PharmSci."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001169","article-title":"Amantadine and rimantadine for preventing and treating influenza A in adults.","author":"Jefferson","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells.","volume":"80","author":"Jones","year":"2006","journal-title":"J. Virol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.antiviral.2013.08.004","article-title":"Efficacy of a single intravenous administration of laninamivir (an active metabolite of laninamivir octanoate) in an influenza virus infection mouse model.","volume":"100","author":"Kakuta","year":"2013","journal-title":"Antiviral Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site:? design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.","volume":"119","author":"Kim","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1128\/AAC.02817-14","article-title":"Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.","volume":"58","author":"Kitano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1128\/AAC.00412-11","article-title":"Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.","volume":"55","author":"Kitano","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1128\/AAC.02324-12","article-title":"Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.","volume":"57","author":"Kitano","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1128\/AAC.01718-10","article-title":"Intravenous peramivir for treatment of influenza A and B virus infection in high-risk patients?.","volume":"55","author":"Kohno","year":"2011a","journal-title":"Antimicrob. Agents Chemother."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1128\/AAC.00474-10","article-title":"Efficacy and safety of intravenous peramivir for treatment of seasonal influenza virus infection.","volume":"54","author":"Kohno","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1128\/AAC.00360-11","article-title":"Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.","volume":"55","author":"Kohno","year":"2011b","journal-title":"Antimicrob. Agents Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jiac.2014.07.006","article-title":"Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.","volume":"20","author":"Komeda","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jiac.2014.11.009","article-title":"Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (II): a pediatric drug use investigation.","volume":"21","author":"Komeda","year":"2015","journal-title":"J. Infect. Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines.","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B79","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature14348","article-title":"Dissemination, divergence and establishment of H7N9 influenza viruses in China.","volume":"522","author":"Lam","year":"2015","journal-title":"Nature"},{"key":"B80","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/irv.12187","article-title":"Peramivir and laninamivir susceptibility of circulating influenza A and B viruses.","volume":"8","author":"Leang","year":"2014","journal-title":"Influenza Other Respir. Viruses"},{"key":"B81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.virol.2005.09.049","article-title":"Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins.","volume":"342","author":"Leser","year":"2005","journal-title":"Virology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1128\/AAC.00065-15","article-title":"Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.","volume":"59","author":"Leu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.2174\/0929867322666150227153919","article-title":"Inhibitors targeting the influenza virus hemagglutinin.","volume":"22","author":"Li","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"B84","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/JVI.69.2.1099-1106.1995","article-title":"Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding.","volume":"69","author":"Liu","year":"1995","journal-title":"J. Virol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/prot.21897","article-title":"Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.","volume":"71","author":"Malaisree","year":"2008","journal-title":"Proteins"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1128\/AAC.50.4.1470-1479.2006","article-title":"Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.","volume":"50","author":"Malakhov","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B87","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1021\/jm00021a007","article-title":"Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition.","volume":"38","author":"Mammen","year":"1995","journal-title":"J. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1345\/aph.1P031","article-title":"Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.","volume":"44","author":"Mancuso","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"B89","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/infdis\/jiu447","article-title":"Characterization of drug-resistant influenza A (H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.","volume":"211","author":"Marjuki","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1021\/jm1002183","article-title":"Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy.","volume":"53","author":"Matsubara","year":"2010","journal-title":"J. Med. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6755","DOI":"10.1128\/AAC.00799-15","article-title":"Population pharmacokinetics of peramivir in healthy volunteers and influenza patients.","volume":"59","author":"Matsuo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B92","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1073\/pnas.73.9.3045","article-title":"Influenza virus genome consists of eight distinct RNA species.","volume":"73","author":"McGeoch","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1517\/14656566.2015.1066336","article-title":"Peramivir: an intravenous neuraminidase inhibitor.","volume":"16","author":"McLaughlin","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"B94","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.antiviral.2014.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012\u20132013.","volume":"110","author":"Meijer","year":"2014","journal-title":"Antiviral Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1086\/651605","article-title":"Rapid selection of oseltamivirand peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts.","volume":"50","author":"Memoli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/irv.12092","article-title":"Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study.","volume":"7(Suppl. 2)","author":"Miller","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial.","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(03)14854-4","article-title":"Influenza.","volume":"362","author":"Nicholson","year":"2003","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.antiviral.2015.02.012","article-title":"Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A (H1N1)pdm09 virus and Streptococcus pneumoniae.","volume":"117","author":"Onishi","year":"2015","journal-title":"Antiviral Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0092-8674(77)90133-7","article-title":"The genes of influenza virus.","volume":"10","author":"Palese","year":"1977","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1099\/0022-1317-33-1-159","article-title":"Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action.","volume":"33","author":"Palese","year":"1976","journal-title":"J. Gen. Virol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1073\/pnas.73.6.2142","article-title":"Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes.","volume":"73","author":"Palese","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"e101325","key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101325","article-title":"Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A (H1N1) infection in mice.","volume":"9","author":"Park","year":"2014","journal-title":"PLoS ONE"},{"key":"B105","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1017\/dmp.2014.156","article-title":"Public acceptance of peramivir during the 2009 H1N1 influenza pandemic: implications for other drugs or vaccines under emergency use authorizations.","volume":"9","author":"Quinn","year":"2015","journal-title":"Disaster Med. Public Health Prep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1399-3062.2010.00582.x","article-title":"Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.","volume":"12","author":"Renaud","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: a first-in-class broad-spectrum antiviral agent.","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antiviral Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"29798","DOI":"10.1074\/jbc.M109.029470","article-title":"Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.","volume":"284","author":"Rossignol","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cell.2009.01.029","article-title":"The influenza virus enigma.","volume":"136","author":"Salomon","year":"2009","journal-title":"Cell"},{"key":"B110","doi-asserted-by":"publisher","first-page":"9609","DOI":"10.1021\/bi00155a013","article-title":"Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography.","volume":"31","author":"Sauter","year":"1992","journal-title":"Biochemistry (Mosc.)"},{"issue":"e64","key":"B111","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q437","article-title":"Pharmacokinetic assessment of peramivir in a hospitalized adult undergoing continuous venovenous hemofiltration.","volume":"45","author":"Scheetz","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"B112","first-page":"17","article-title":"[Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein].","volume":"55","author":"Semenova","year":"2010","journal-title":"Vopr. Virusol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1586\/eri.11.174","article-title":"Peramivir for the treatment of influenza.","volume":"10","author":"Shetty","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1128\/AAC.45.3.749-757.2001","article-title":"In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201.","volume":"45","author":"Sidwell","year":"2001a","journal-title":"Antimicrob. Agents Chemother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0166-3542(01)00149-8","article-title":"Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.","volume":"51","author":"Sidwell","year":"2001b","journal-title":"Antiviral Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2010.07.003","article-title":"Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.","volume":"88","author":"Smee","year":"2010","journal-title":"Antiviral Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0166-3542(01)00168-1","article-title":"Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.","volume":"52","author":"Smee","year":"2001","journal-title":"Antiviral Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cis351","article-title":"Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus.","volume":"55","author":"Sorbello","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1021\/bi0205449","article-title":"Influenza neuraminidase inhibitors:? structure-based design of a novel inhibitor series.","volume":"42","author":"Stoll","year":"2003","journal-title":"Biochemistry (Mosc.)"},{"key":"B120","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/AAC.00132-11","article-title":"Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.","volume":"56","author":"Sugaya","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/AAC.46.4.996-1004.2002","article-title":"Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection.","volume":"46","author":"Sweet","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"20666","key":"B122","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.1.20666","article-title":"A community cluster of influenza A (H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, november to december 2013.","volume":"19","author":"Takashita","year":"2014","journal-title":"Euro. Surveill"},{"key":"B123","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1289\/ehp.1002383","article-title":"Global influenza seasonality: reconciling patterns across temperate and tropical regions.","volume":"119","author":"Tamerius","year":"2010","journal-title":"Environ. Health Perspect."},{"issue":"140","key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00140","article-title":"An overview of the characteristics of the novel avian influenza A H7N9 virus in humans.","volume":"6","author":"Tan","year":"2015","journal-title":"Front. Microbiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3851\/IMP2744","article-title":"The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.","volume":"20","author":"Tanaka","year":"2015","journal-title":"Antivir. Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1073\/pnas.0402630101","article-title":"Protection against lethal influenza virus challenge by RNA interference in vivo.","volume":"101","author":"Tompkins","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B127","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","article-title":"A distinct lineage of influenza A virus from bats.","volume":"109","author":"Tong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"e1003657","key":"B128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003657","article-title":"New world bats harbor diverse influenza A viruses.","volume":"9","author":"Tong","year":"2013","journal-title":"PLoS Pathog."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial.","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"key":"B130","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors.","volume":"6","author":"von Itzstein","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"B131","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","article-title":"Rational design of potent sialidase-based inhibitors of influenza virus replication.","volume":"363","author":"von Itzstein","year":"1993","journal-title":"Nature"},{"key":"B132","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses.","volume":"56","author":"Webster","year":"1992","journal-title":"Microbiol. Rev."},{"key":"B133","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/id500022h","article-title":"A potent anti-influenza compound blocks fusion through stabilization of the prefusion conformation of the hemagglutinin protein.","volume":"1","author":"White","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"B134","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3851\/IMP2874","article-title":"Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.","volume":"20","author":"Whitley","year":"2014","journal-title":"Antivir. Ther."},{"key":"B135","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1128\/CMR.00097-12","article-title":"Traditional and new influenza vaccines.","volume":"26","author":"Wong","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"B136","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2014.01.010","article-title":"Bat-derived influenza-like viruses H17N10 and H18N11.","volume":"22","author":"Wu","year":"2014","journal-title":"Trends Microbiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"e110026","key":"B138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110026","article-title":"A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucus.","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS ONE"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/jmv.24232","article-title":"Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.","volume":"87","author":"Yoo","year":"2015","journal-title":"J. Med. Virol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/crj.12129","article-title":"Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.","volume":"9","author":"Yoshino","year":"2015","journal-title":"Clin. Respir. J."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1098\/rstb.2001.1004","article-title":"RWJ-270201 (BCX-1812): a novel neuraminidase inhibitor for influenza.","volume":"356","author":"Young","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/cid\/cis352","article-title":"Peramivir use for treatment of hospitalized patients with influenza A (H1N1)pdm09 under emergency use authorization, october 2009\u2013june 2010.","volume":"55","author":"Yu","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B143","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.virol.2007.12.029","article-title":"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A\/Vietnam\/1203\/04 (H5N1).","volume":"374","author":"Yun","year":"2008","journal-title":"Virology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000365758","article-title":"Characterization of human influenza viruses in lebanon during 2010-2011 and 2011-2012 post-pandemic seasons.","volume":"57","author":"Zaraket","year":"2014","journal-title":"Intervirology"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/jmv.21795","article-title":"Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.","volume":"82","author":"Zaraket","year":"2010","journal-title":"J. Med. Virol."},{"issue":"e78","key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.80","article-title":"Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution.","volume":"3","author":"Zhang","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"B147","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coviro.2016.01.020","article-title":"Emergence and development of H7N9 influenza viruses in China.","volume":"16","author":"Zhu","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"e29120","key":"B148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029120","article-title":"Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T11:26:17Z","timestamp":1718450777000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00450\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":148,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00450","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}